2 Monster Growth Stocks to Sell Before They Fall 56% and 64% in 2025, According to Wall Street Analysts
JPMorgan Chase analysts expect shares of Circle Internet Group and Tesla to decline sharply in the remaining months of the year.
Circle is the issuer of USDC, the second largest stablecoin by market value, but the stock is hard to value because the company has only been public for a few months.
Tesla has lost substantial market share in electric vehicles this year, but the company recently introduced its first commercial autonomous ride-hailing service.
These 10 stocks could mint the next wave of millionaires ›
Circle Internet Group (NYSE: CRCL) shares have advanced 120% since the company held its initial public offering in June, and Tesla (NASDAQ: TSLA) shares have climbed 160% since the beginning of 2023. However, JPMorgan Chase analysts expect the monster growth stocks to declined sharply in the remaining months of the year.
Ken Worthington at JPMorgan has set Circle with a year-end target price of $80 per share. That implies 56% downside from its current share price of $182.
Ryan Brinkman at JPMorgan has set Tesla with a year-end target price of $115 per share. That implies 64% downside from its current share price of $321.
Importantly, most Wall Street analysts are less bearish, but very few expect material upside in the stocks. The average target on Circle is $181.50 per share, which implies no change from its current price. And the average target on Tesla is $310 per share, which implies 3% downside from its current price.
Here's what investors should know.
Circle Internet Group: 56% implied downside
Circle is on a mission to improve the global financial system by enabling a frictionless exchange of value with stablecoins, cryptocurrencies tied to the value of fiat currencies. The company is best known for its U.S. dollar-denominated USDC (CRYPTO: USDC), the seventh largest cryptocurrency by market value. But Circle is also the issuer of the European euro-denominated EURC (CRYPTO: EURC).
Those stablecoins are fully backed by fiat currency, and Circle currently generates most of its revenue from interest earned on those reserve assets. However, the company recently expanded into payment processing. The Circle Payments Network will support a broad range of money movement use cases, such as supplier payments, remittances, and payroll.
Circle has yet to report financial results as a public company, but its recently filed Form S-1 shows the following for the first quarter: Revenue increased 59% to $579 million because of a large increase in circulating USDC, offset by lower interest rates. And adjusted EBITDA rose 60% to $122 million. Investors have good reason to believe the company can maintain its momentum.
Today, Stablecoins have a collective market value of $260 billion. But Seaport Research analyst Jeff Cantwell estimates that figure will nearly double to reach $500 billion in 2026, and could eventually reach $2 trillion. In turn, Cantwell thinks Circle's revenue will grow at 25% to 30% per year as the stablecoin market expands.
This stock is hard to value, given Circle has been a public company for only a few months. However, the current multiples of 21 times sales and 189 times forward earnings are not cheap, leaving plenty of room for the share price to fall. I am skeptical about the 56% drop implied by JPMorgan's target price, but investors should limit exposure to Circle stock until the company has been public for a few quarters.
Tesla: 64% implied downside
Tesla has lost significant market share in electric vehicles in the past year because of increased competition and brand damage inflicted by CEO Elon Musk, who has managed to irritate both major U.S. political parties. Tesla accounted for 10% of battery electric vehicle sales through May, down from 16% in the same period last year, per Morgan Stanley.
Tesla reported dismal second-quarter financial results. Deliveries dropped 13%, the second straight decline. In turn, revenue declined 12% to $22 billion, operating margin contracted 2 percentage points, and non-GAAP net income declined 23% to $0.40 per diluted share. Musk also warned the next few quarters could be rough, but he remains upbeat about the long-term narrative.
Musk thinks Tesla can eventually be the most valuable company in the world if it executes on opportunities in autonomous driving and robotics. Tesla recently introduced a robotaxi service in Austin, and Musk says the coverage area may include half the U.S. population by year's end. That would put the company ahead of the market leader Alphabet's Waymo, which operates in only five U.S. cities.
Musk during the earnings call also talked about the humanoid robot Optimus. He expects production to reach 100,000 units monthly within five years, or at least 1 million units annually. He has previously estimated humanoid robots will be a $10 trillion opportunity for Tesla, meaning Optimus may eventually be its largest source of revenue.
Wall Street expects Tesla's earnings to grow at 20% annually over the next three years. That makes the current valuation of 186 times earnings look outrageously expensive. I doubt shares will fall 64%, unless something goes wrong with the robotaxis or robots, but investors should still keep their positions small until Tesla makes more progress in those nascent areas of its business.
Should you buy stock in Tesla right now?
The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $630,291!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,075,791!*
Now, it's worth noting Stock Advisor's total average return is 1,039% — a market-crushing outperformance compared to 182% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor.
See the 10 stocks »
*Stock Advisor returns as of July 29, 2025
JPMorgan Chase is an advertising partner of Motley Fool Money. Trevor Jennewine has positions in Tesla. The Motley Fool has positions in and recommends Alphabet, JPMorgan Chase, and Tesla. The Motley Fool has a disclosure policy.
2 Monster Growth Stocks to Sell Before They Fall 56% and 64% in 2025, According to Wall Street Analysts was originally published by The Motley Fool
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
20 minutes ago
- Yahoo
GE HealthCare Technologies Second Quarter 2025 Earnings: EPS Beats Expectations
GE HealthCare Technologies (NASDAQ:GEHC) Second Quarter 2025 Results Key Financial Results Revenue: US$5.01b (up 3.5% from 2Q 2024). Net income: US$486.0m (up 14% from 2Q 2024). Profit margin: 9.7% (in line with 2Q 2024). EPS: US$1.06 (up from US$0.94 in 2Q 2024). We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. All figures shown in the chart above are for the trailing 12 month (TTM) period GE HealthCare Technologies EPS Beats Expectations Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 19%. Looking ahead, revenue is forecast to grow 4.1% p.a. on average during the next 3 years, compared to a 8.2% growth forecast for the Medical Equipment industry in the US. Performance of the American Medical Equipment industry. The company's shares are down 10.0% from a week ago. Valuation Our analysis of these results suggests GE HealthCare Technologies may be undervalued based on 6 important criteria we look at. To explore our complete evaluation click here and get an understanding of what analysts are thinking about the company's future. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


Business Insider
29 minutes ago
- Business Insider
Maxim Group Keeps Their Buy Rating on Amazon (AMZN)
In a report released yesterday, Tom Forte from Maxim Group reiterated a Buy rating on Amazon. The company's shares closed yesterday at $214.75. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. According to TipRanks, Forte is a 4-star analyst with an average return of 6.8% and a 44.26% success rate. Forte covers the Consumer Cyclical sector, focusing on stocks such as Jakks Pacific, Beyond Inc, and Allbirds. In addition to Maxim Group, Amazon also received a Buy from Piper Sandler's Thomas Champion in a report issued yesterday. However, on the same day, Wells Fargo reiterated a Hold rating on Amazon (NASDAQ: AMZN). Based on Amazon's latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $155.67 billion and a net profit of $17.13 billion. In comparison, last year the company earned a revenue of $143.31 billion and had a net profit of $10.43 billion
Yahoo
34 minutes ago
- Yahoo
UnitedHealth Group Announces Changes to Leadership Team
July 31, 2025--(BUSINESS WIRE)--UnitedHealth Group (NYSE: UNH) today announced Wayne S. DeVeydt has been appointed its chief financial officer, effective September 2, 2025. John F. Rex, who joined the company in 2012 and has been CFO since 2016, will become strategic advisor to the CEO on the same date. "Wayne DeVeydt combines deep financial acumen and operating experience with the mission-oriented and compassionate approach to health care that is a perfect fit for UnitedHealth Group," said Stephen J. Hemsley, company chairman and chief executive officer. "John Rex has been an exceptional leader, having helped guide our company through substantial change with both strategic vision and strong commitment to our mission," said Hemsley. "I look forward to his continued insights as UnitedHealth Group moves forward." DeVeydt, 55, most recently has been a managing director and operating partner at Bain Capital, working with client leaders on operational improvement and growth acceleration. From 2018-2020, he was chairman and CEO of Surgery Partners, Inc. in Nashville, expanding the operational scale and financial performance of the surgical services firm. He joined Anthem, Inc. (now Elevance) in 2005 and served as its chief financial officer from 2007 to 2016. Prior to joining Anthem, DeVeydt served as a partner with PricewaterhouseCoopers LLP, with a focus on the health care sector. "There is no organization besides UnitedHealth Group that presents the kinds of opportunities to make a difference in health care, from individual patient care to broad system efficiency, so I am eagerly looking forward to joining the team," said DeVeydt. "I've been fortunate to know John Rex for over two decades and am honored to follow a leader of his caliber." Rex, 63, joined UnitedHealth Group as chief financial officer of the company's then newly established Optum business and previously had spent his career focused in health care across multiple roles and sectors. "This pivotal moment for UnitedHealth Group is the right time for a new yet greatly experienced executive like Wayne DeVeydt, and I look forward to supporting him and the entire leadership team while continuing to advise on a range of matters," said Rex. About UnitedHealth Group UnitedHealth Group is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone through two distinct and complementary businesses. Optum delivers care aided by technology and data, empowering people, partners and providers with the guidance and tools they need to achieve better health. UnitedHealthcare offers a full range of health benefits, enabling affordable coverage, simplifying the health care experience and delivering access to high-quality care. Visit UnitedHealth Group at and follow UnitedHealth Group on LinkedIn. View source version on Contacts Media: uhgmedia@ UnitedHealth Group Media Sign in to access your portfolio